219 related articles for article (PubMed ID: 19923144)
1. Outcome of atrial fibrillation among patients with end-stage renal disease.
Chou CY; Kuo HL; Wang SM; Liu JH; Lin HH; Liu YL; Huang CC
Nephrol Dial Transplant; 2010 Apr; 25(4):1225-30. PubMed ID: 19923144
[TBL] [Abstract][Full Text] [Related]
2. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.
Hohnloser SH; Pajitnev D; Pogue J; Healey JS; Pfeffer MA; Yusuf S; Connolly SJ;
J Am Coll Cardiol; 2007 Nov; 50(22):2156-61. PubMed ID: 18036454
[TBL] [Abstract][Full Text] [Related]
3. Chronic kidney disease and CHADS(2) score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillation.
Nakagawa K; Hirai T; Takashima S; Fukuda N; Ohara K; Sasahara E; Taguchi Y; Dougu N; Nozawa T; Tanaka K; Inoue H
Am J Cardiol; 2011 Mar; 107(6):912-6. PubMed ID: 21247518
[TBL] [Abstract][Full Text] [Related]
4. Stroke prediction using mean platelet volume in patients with atrial fibrillation.
Ha SI; Choi DH; Ki YJ; Yang JS; Park G; Chung JW; Koh YY; Chang KS; Hong SP
Platelets; 2011; 22(6):408-14. PubMed ID: 21599611
[TBL] [Abstract][Full Text] [Related]
5. Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1.
Gorin L; Fauchier L; Nonin E; de Labriolle A; Haguenoer K; Cosnay P; Babuty D; Charbonnier B
Thromb Haemost; 2010 Apr; 103(4):833-40. PubMed ID: 20135077
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.
Ruiz-Nodar JM; Marín F; Hurtado JA; Valencia J; Pinar E; Pineda J; Gimeno JR; Sogorb F; Valdés M; Lip GY
J Am Coll Cardiol; 2008 Feb; 51(8):818-25. PubMed ID: 18294566
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
8. Preexisting atrial fibrillation as predictor for late-time mortality in patients with end-stage renal disease undergoing cardiac surgery--a multicenter study.
Schönburg M; Ziegelhoeffer T; Weinbrenner F; Bechtel M; Detter C; Krabatsch T; Osswald B; Riess FC; Scholz F; Stamm C; Sievers HH; Bartels C
Thorac Cardiovasc Surg; 2008 Apr; 56(3):128-32. PubMed ID: 18365969
[TBL] [Abstract][Full Text] [Related]
9. Delayed detection of atrial fibrillation after ischemic stroke.
Kamel H; Lees KR; Lyden PD; Teal PA; Shuaib A; Ali M; Johnston SC;
J Stroke Cerebrovasc Dis; 2009; 18(6):453-7. PubMed ID: 19900647
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study.
Pappone C; Augello G; Sala S; Gugliotta F; Vicedomini G; Gulletta S; Paglino G; Mazzone P; Sora N; Greiss I; Santagostino A; LiVolsi L; Pappone N; Radinovic A; Manguso F; Santinelli V
J Am Coll Cardiol; 2006 Dec; 48(11):2340-7. PubMed ID: 17161267
[TBL] [Abstract][Full Text] [Related]
11. Stroke event rates in anticoagulated patients with paroxysmal atrial fibrillation.
Lip GY; Frison L; Grind M;
J Intern Med; 2008 Jul; 264(1):50-61. PubMed ID: 18266660
[TBL] [Abstract][Full Text] [Related]
12. Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) Registry.
Winkel TA; Hoeks SE; Schouten O; Zeymer U; Limbourg T; Baumgartner I; Bhatt DL; Steg PG; Goto S; Röther J; Cacoub PP; Verhagen HJ; Bax JJ; Poldermans D
Eur J Vasc Endovasc Surg; 2010 Jul; 40(1):9-16. PubMed ID: 20385507
[TBL] [Abstract][Full Text] [Related]
13. Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: clinical correlates and the effect of rhythm-control therapy.
De Vos CB; Breithardt G; Camm AJ; Dorian P; Kowey PR; Le Heuzey JY; Naditch-Brûlé L; Prystowsky EN; Schwartz PJ; Torp-Pedersen C; Weintraub WS; Crijns HJ
Am Heart J; 2012 May; 163(5):887-93. PubMed ID: 22607868
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
Wachtell K; Lehto M; Gerdts E; Olsen MH; Hornestam B; Dahlöf B; Ibsen H; Julius S; Kjeldsen SE; Lindholm LH; Nieminen MS; Devereux RB
J Am Coll Cardiol; 2005 Mar; 45(5):712-9. PubMed ID: 15734615
[TBL] [Abstract][Full Text] [Related]
15. Effect of atrial fibrillation pattern on survival in a community-based cohort.
Keating RJ; Gersh BJ; Hodge DO; Weivoda PL; Patel PJ; Hammill SC; Shen WK
Am J Cardiol; 2005 Nov; 96(10):1420-4. PubMed ID: 16275191
[TBL] [Abstract][Full Text] [Related]
16. Atrial fibrillation significantly increases total mortality and stroke risk beyond that conveyed by the CHADS2 risk factors.
Crandall MA; Horne BD; Day JD; Anderson JL; Muhlestein JB; Crandall BG; Weiss JP; Osborne JS; Lappé DL; Bunch TJ
Pacing Clin Electrophysiol; 2009 Aug; 32(8):981-6. PubMed ID: 19659615
[TBL] [Abstract][Full Text] [Related]
17. [SFAAT: the study of nonrheumatic chronic atrial fibrillation in the Trieste area. Results of an enrollment study].
Scardi S; Mazzone C; Goldstein D; Pandullo C; Poletti A; Humar F; Pivotti F; De Santis C
G Ital Cardiol; 1995 Feb; 25(2):173-82. PubMed ID: 7642022
[TBL] [Abstract][Full Text] [Related]
18. Atrial fibrillation in haemodialysis patients: do the guidelines for anticoagulation apply?
To AC; Yehia M; Collins JF
Nephrology (Carlton); 2007 Oct; 12(5):441-7. PubMed ID: 17803466
[TBL] [Abstract][Full Text] [Related]
19. Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events.
Botto GL; Padeletti L; Santini M; Capucci A; Gulizia M; Zolezzi F; Favale S; Molon G; Ricci R; Biffi M; Russo G; Vimercati M; Corbucci G; Boriani G
J Cardiovasc Electrophysiol; 2009 Mar; 20(3):241-8. PubMed ID: 19175849
[TBL] [Abstract][Full Text] [Related]
20. Ten-year experience with the Cox-maze procedure for atrial fibrillation: how do we define success?
Stulak JM; Sundt TM; Dearani JA; Daly RC; Orsulak TA; Schaff HV
Ann Thorac Surg; 2007 Apr; 83(4):1319-24. PubMed ID: 17383333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
